Ignite Creation Date:
2024-05-06 @ 3:27 AM
Last Modification Date:
2024-10-26 @ 11:34 AM
Study NCT ID:
NCT02298166
Status:
TERMINATED
Last Update Posted:
2021-10-06
First Post:
2014-11-19
Brief Title:
Study of Crenolanib in Combination With Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia and Activating FLT3 Mutations
Sponsor:
University of Ulm
Organization:
University of Ulm
Organization Data
Organization:
University of Ulm
Class:
OTHER
Study ID:
AMLSG 19-13 ARO-007
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Ulm
Lead Sponsor Class:
OTHER
Responsible Party:
Prof Dr Hartmut Doehner
Responsible Party Title:
Prof Dr
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
University of Ulm
Old Name:
None
Old Organization:
None